← All trials
NCT00711035
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 1, 2008
- Primary completion
- Oct 1, 2012
- Completion date
- Aug 1, 2013
- First posted
- —
- Last posted
- —
- Enrollment
- 50
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- Baylor UniversityLead sponsor
- Baylor UniversityOverall official - principal investigator
- National Marrow Donor ProgramCollaborator
- The EMMES CorporationCollaborator
- Duke UniversityCollaborator
- National Heart, Lung, and Blood Institute (NHLBI)Collaborator
- University of MiamiCollaborator
- University of California, Los AngelesCollaborator
- University of Southern CaliforniaCollaborator
- University of Texas at HoustonCollaborator
- Baylor UniversityCollaborator
- Baylor UniversityReponsible party - principal investigator
- Rutgers UniversityCollaborator
- Harvard UniversityCollaborator
- Methodist Cancer Center, Houston, TexasCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.